Trial intelligence / Profile preview

BERT: Immunological Effects of aP Booster

NCT03697798Phase 4Completed

Sponsor
University of Oxford
Start
Apr 2018
Primary completion
Jan 2020
Modality
Vaccines & Immunotherapeutics
Countries
3
01

Overview

A Phase 4 trial of Boostrix Polio in pertussis, sponsored by University of Oxford. Started Apr 2018; status: completed.

02

Drugs

Boostrix Polio
03

Conditions

pertussis

Beyond the preview

Go deeper on NCT03697798.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03697798.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call